Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT05125419
NCT05125419CompletedNot Applicable

Serum Homocysteine Level in the Setting of Acute Coronary Syndrome in Young Adult Patients

Sohag University1 site in 1 country100 target enrollmentStarted: November 30, 2021Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
1
Primary Endpoint
Coronary care unit admission with acute coronary syndrome
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This study aims to determine the relation between high homocysteine levels and increased incidence of acute coronary syndrome in young patients

Detailed Description

Cross sectional study to:

assess homocysteine level in young adult patients presenting with acute coronary syndrome

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •The patients who presented in the hospital with chest pain consistent with acute coronary syndrome with any of the following features:
  • •Electrocardiogram (ECG) changes:
  • •ST elevation
  • •ST depression
  • •T wave inversion
  • •recent left bundle branch block
  • •Troponin T elevation (Norma value < 0.06)
  • •2- Age: -Between 18- 40 years (Group A) - Age > 40 years (Group B)

Exclusion Criteria

  • •Chest pain not consistent with acute coronary syndrome
  • •Chronic kidney disease (CKD)
  • •Rheumatic heart disease (RHD)
  • •Congenital heart disease

Outcomes

Primary Outcomes

Coronary care unit admission with acute coronary syndrome

Time Frame: From date of randomization up to 1 month

Acute coronary syndrome hospitalization and cardiovascular deathes and estimated hazard ratios (HR) by use of multivariable Cox regression models

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mahmoud Abdelnasser Labib

Principal investigator

Sohag University

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Homocysteine and Coronary Artery DiseaseCoronary Arterial Disease (CAD)
NCT06675890Shaqra University381
Completed
Not Applicable
The Study of Relationship of Plasma Concentrations of Folic Acid, Vitamin B and Homocysteine With Carotid Atherosclerosis and Endothelium-Dependent Vasodilatation of Geriatric and Young Patients in the Ambulatory Care Department of NTUHHomocysteineCoronary Artery Disease
NCT00172250National Taiwan University Hospital
Completed
Not Applicable
Serum Total Homocysteine and C-Reactive Protein - Ancillary to IDNTCardiovascular DiseasesHeart DiseasesDiabetes Mellitus, Non-insulin DependentHypertensionDiabetes MellitusAtherosclerosis
NCT00021918National Heart, Lung, and Blood Institute (NHLBI)
Withdrawn
Not Applicable
Effects of Homocysteine in Myocardial Infarction Patients in a Tertiary Care Hospital of PakistanMetabolic Disorder Homocystine
NCT05011032Aqua Medical Services (Pvt) Ltd
Not yet recruiting
Phase 4
Homocysteine, inflammatory factors, safety study of scutellarin for injection in patients with acute cerebral infarction - a single center, randomized, open label clinical trialAcute cerebral infarction
ITMCTR2100005042Yunnan Third People's Hospital